Researchers reported a standardized pathology and molecular workflow designed to turn frozen tumor samples collected across countries and sites into reliable whole-genome data. The Mutographs project, led by the Wellcome Sanger Institute and funded by partners, aims to reduce variability introduced by different collection and processing conditions. The approach is designed to preserve data quality for large-scale cancer genomics where frozen samples are more feasible than fresh tissue, especially in multi-center studies spanning heterogeneous sample sources. The workflow is positioned as a way to ensure that genomic outputs remain comparable across sites for downstream analyses. If adopted broadly, the protocol could improve the consistency of international cancer genomics efforts and make it easier to integrate datasets for subtype discovery, biomarker development, and other translational applications that depend on high-fidelity whole-genome information. The work also highlights how logistics and sample handling are increasingly treated as key determinants of genomic study reliability.